CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...

Joyner, who heads CVS’s pharmacy-benefit business Caremark, will succeed Karen Lynch.

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's ...

CVS Health announced Friday it has appointed David Joyner as its new Chief Executive Officer, replacing Karen Lynch.

The struggling pharmacy chain said Friday that the change in leadership is effective immediately. Lynch had been CEO since ...

另外，西维斯健康公布的初步业绩数据显示，第三季度初步调整后 每股收益 为1.05至1.10美元，不及市场预期的1.7美元，取消了2024年的盈利指引，并警告称，“鉴于其医疗保健福利部门的医疗成本压力持续上升”，投资者不要依赖该公司此前的指引。

CVS has replaced CEO Karen Lynch with longtime pharmacy benefits executive David Joyner. The company has been struggling to ...

Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest ...

CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.

10月18日｜美国最大药品零售公司西维斯健康 (CVS.US) 盘中大跌9%至57.94美元。 根据声明，该公司任命David Joyner为新任首席执行官，结束了现任首席执行官Karen Lynch在这家药品零售巨头的动荡任期。

另外，西维斯健康公布的初步业绩数据显示，第三季度初步调整后每股收益为1.05至1.10美元，不及市场预期的1.7美元，取消了2024年的盈利指引，并警告称，“鉴于其医疗保健福利部门的医疗成本压力持续上升”，投资者不要依赖该公司此前的指引。

罗得岛州WOONSOCKET - CVS Health (NYSE:CVS) 宣布了一项重大领导层变动，David Joyner自上周四起担任总裁兼首席执行官。Joyner拥有37年的医疗保健和药房福利管理背景，接替Karen Lynch的职位。同时，Roger Farah从董事长转任为执行董事长。 Joyner此前曾担任CVS Health执行副总裁和CVS Caremark总裁。他在管理药房服 ...